Sept 20 (Reuters) - Swiss medical technology company Ypsomed announced on Wednesday a long-term supply deal with Novo Nordisk for autoinjectors, the latest sign of how the Danish drugmaker's ...
Novo Nordisk has spent the last two years scrambling to keep up with skyrocketing demand for its blockbuster GLP-1 drugs, the obesity-focused Wegovy and Type 2 diabetes med Ozempic, forcing it to ...
The Swiss diabetes hardware company Ypsomed is selling off its insulin pen needle and blood sugar monitoring operations, as it turns its attention toward its drug autoinjectors and digital insulin ...
Sept 20 (Reuters) - Swiss medical technology company Ypsomed (YPSN.S), opens new tab announced on Wednesday a long-term supply deal with Novo Nordisk (NOVOb.CO), opens new tab for autoinjectors, the ...
(Reuters) -Swiss medical technology company Ypsomed announced on Wednesday a long-term supply deal with Novo Nordisk for autoinjectors, the latest sign of how the Danish drugmaker's weight-loss drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results